Thomas Shelter

Thomas Shelter has been a keen follower of US politics for over two decades. His reporting for Congress.net primarily focuses on legislation, party politics, and business news.

GSK (GSK) Seals $10.6 Billion Nuvalent Acquisition In Largest Deal For Cancer Portfolio In Over A Decade

British drugmaker GSK has agreed to acquire U.S.-listed oncology specialist Nuvalent in an all-cash deal valued at $10.6 billion. The transaction values Boston-based Nuvalent at approximately $124 per share, representing a 40% premium to its last closing price. Net of cash acquired, GSK’s aggregate investment is estimated at $9.4 billion, with the deal primarily funded…

Read More

Trump Administration Eyes Equity Stakes In AI Firms As OpenAI And Anthropic Near Public Markets

The federal government is in preliminary talks with major artificial intelligence companies about taking ownership stakes in the rapidly expanding sector. President Donald Trump confirmed Friday that his administration is actively considering acquiring government equity positions in leading AI developers. Speaking to reporters aboard Air Force One, Trump said discussions had already taken place with…

Read More

Morgan Stanley’s Top Strategist Says Tech’s Record Pullback Is A Healthy Bull Market Reset

The technology sector has experienced a significant pullback in recent months, rattling investors who had grown accustomed to relentless gains across major indices. Despite the turbulence, Morgan Stanley’s top stock-market strategist is urging calm, characterizing the selloff as a natural and necessary correction within a broader bull market. The strategist’s assessment frames the retreat not…

Read More